Picture of Mesa Laboratories logo

MLAB — Mesa Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Mesa Laboratories Inc reports results for the quarter ended in June - Earnings Summary

* Mesa Laboratories Inc  MLAB.OQ  reported quarterly
adjusted
earnings of 84 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -10 cents.  The mean expectation of
three analysts for the quarter was for earnings of 44 cents per
share. Wall Street expected results to range from -17 cents
to $1.55 per share.
    * Revenue rose 14.9% to $58.17 million from a year ago;
analysts
expected $55.75 million. 
    * Mesa Laboratories Inc's reported EPS for the quarter was
62
cents​.
    * The company reported quarterly net income of $3.39
million.
    * Mesa Laboratories Inc shares had risen by 23.2% this
quarter and
gained 2.0% so far this year.

FORECAST CHANGES
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Mesa Laboratories
Inc is $118.00 
This summary was machine generated from LSEG data August 5 at
01:30 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      0.44           0.84           Beat
 Mar. 31 2024      -0.11          3.70           Beat
 Dec. 31 2023      0.19           0.39           Beat
 Sep. 30 2023      0.16           -0.23          Missed

Recent news on Mesa Laboratories

See all news